2 High-Performing Stocks with Strong Financials and 1 Encountering Challenges

Not Every Profitable Company Is Built to Last

Some businesses may show strong profits today, but that doesn’t guarantee long-term success. Many rely on outdated strategies or temporary advantages, so being in the black now doesn’t ensure future growth.

How StockStory Helps You Find Standout Companies

Profitability alone doesn’t make all companies equal. That’s why StockStory exists—to help you identify businesses with sustainable earnings and real growth potential. Below, we highlight two companies with consistent profits and growth, as well as one that may face challenges ahead.

Stock to Consider Selling

Golden Entertainment (GDEN)

Trailing 12-Month GAAP Operating Margin: 3.4%

Golden Entertainment (NASDAQ:GDEN), established in 2001, operates casinos, taverns, and distributed gaming platforms.

Reasons to Reconsider GDEN

• Over the past five years, annual revenue has dropped by 1.8%, suggesting difficulties in maintaining its market position.
• With a free cash flow margin of just 6% for the last two years, the company has limited flexibility to invest or return capital to shareholders through buybacks or dividends.
• Returns on capital have declined from an already low base, indicating that both past and current investments are falling short of expectations.

Currently, Golden Entertainment trades at $29.31 per share, reflecting a forward P/E of 33.6.

Two Promising Stocks to Watch

Amgen (AMGN)

Trailing 12-Month GAAP Operating Margin: 24.7%

Founded in 1980, Amgen (NASDAQ:AMGN) is a leader in biotechnology, developing and producing innovative therapies for serious conditions such as cancer, osteoporosis, and autoimmune disorders.

Why Amgen Stands Out

• Amgen’s revenue has grown by 14.2% annually over the past two years, outpacing industry averages as its products gain traction with customers.
• With $36.75 billion in revenue, the company benefits from significant scale and bargaining power.
• Strong free cash flow allows Amgen to invest in future growth or return value to shareholders through buybacks and dividends.

At $383.69 per share, Amgen’s forward P/E is 17.3.

Ameriprise Financial (AMP)

Trailing 12-Month GAAP Operating Margin: 36.9%

Ameriprise Financial (NYSE:AMP), founded in 1894 and spun off from American Express in 2005, offers financial planning, wealth management, asset management, and insurance solutions for individuals and institutions.

Why We’re Positive on AMP

• Share buybacks over the past five years have helped annual earnings per share grow by 22.8%, outpacing revenue growth.
• The company’s tangible book value per share has surged by 43.5% annually over the last two years, reflecting strong equity growth.
• With a return on equity of 62.4%, Ameriprise demonstrates exceptional skill in generating profitable investments.

Ameriprise Financial is currently priced at $474.61 per share, with a forward P/E of 11.

Top-Quality Stocks for Any Market Environment

Discover Our Top 9 Market-Beating Stocks
The best-performing stocks don’t just outperform once—they do so repeatedly. These companies deliver strong revenue growth, rising free cash flow, and industry-leading returns on capital, earning recognition from the market.

Our AI-driven platform believes these winners still have room to run. Want to know which nine stocks made our list this week?

Our 2020 picks included well-known names like Nvidia (up 1,326% from June 2020 to June 2025) and lesser-known companies such as Kadant, which delivered a 351% five-year return.